- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Measurement of N-terminal pro-B-type natriuretic peptide(NT-proBNP)in hemodialysis patients-Examination by electrocardiogram-
-
- Tsutaya Chikako
- Oyokyo Kidney Research Institute
-
- Tsushima Megumi
- Oyokyo Kidney Research Institute
-
- Terayama Yuriko
- Oyokyo Kidney Research Institute
-
- Yamaya Kanemitsu
- Oyokyo Kidney Research Institute
-
- Saitoh Hisao
- Oyokyo Kidney Research Institute
-
- Funyu Tomihisa
- Oyokyo Kidney Research Institute
Bibliographic Information
- Other Title
-
- 血液透析患者のNT-proBNP濃度測定の有用性 ‐心電図所見からの検討‐
- 血液透析患者のNT-proBNP濃度測定の有用性--心電図所見からの検討
- ケツエキ トウセキ カンジャ ノ NT proBNP ノウド ソクテイ ノ ユウヨウセイ シンデンズ ショケン カラ ノ ケントウ
- ―心電図所見からの検討―
Search this article
Description
N-terminal pro-B-type natriuretic peptide(NT-proBNP) is a new biomarker of both the cardiac function and heart failure. The serum concentrations of NT-proBNP increase in hemodialysis(HD) patients. This study examined the usefulness of NT-proBNP measurement in HD patients by examining the relationship between NT-proBNP and electrocardiographic(ECG) findings. This study observed 85 HD patients. The serum concentrations of NT-proBNP were measured by an electrochemiluminescence immunoassay(Elecsys 2010, Roche Diagnosics). RV5+SV1 voltage, RV5 voltage, QRS interval, QTc interval and QRS axis were used as ECG parameters. The serum NT-proBNP concentrations in HD patients(676~127,172 pg/mL) were significantly higher than healthy subjects(9~144 pg/mL). There was a significant positive correlation between NT-proBNP and RV5+SV1 voltage. A receiver-operating characteristic curve demonstrated about 8,000 pg/mL as the cut-off value for NT-proBNP that correlated with cardiac function abnormalities. HD patients were divided into two groups based on their NT-proBNP concentrations(<8,000 pg/mL group and ≥8,000 pg/mL group). The incidence of heart failure in the <8,000 pg/mL group was compared with that in the ≥8,000 pg/mL group. The incidence of heart failure in the ≥8,000 pg/mL group was 31.4%, which was significantly higher than that in the <8,000 pg/mL group;0.0%(p<0.0001). These findings suggest that the NT-proBNP concentrations are a useful marker of cardiac function as well as a predictor of heart failure in HD patients. The NT-proBNP cut-off value in HD patients was thus determined to be 8,000 pg/mL.
Journal
-
- Nihon Toseki Igakkai Zasshi
-
Nihon Toseki Igakkai Zasshi 43 (8), 633-640, 2010
The Japanese Society for Dialysis Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204680452096
-
- NII Article ID
- 10026622438
-
- NII Book ID
- AN10432053
-
- ISSN
- 1883082X
- 13403451
-
- NDL BIB ID
- 10818371
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed